# Linde timeline entity: /record/linde.md id: ent_linde Linde's timeline holds 310 claims from 2015 to 2026: 296 money & deals, 14 other. 12 are undated. The latest took effect on September 30, 2026. Kinds: People 0 (/timelines/linde.md?kind=people) · Money & deals 296 (/timelines/linde.md?kind=money) · Products 0 (/timelines/linde.md?kind=products) · Models 0 (/timelines/linde.md?kind=models) · Other 14 (/timelines/linde.md?kind=other) Format: date | kind | predicate | value | status | claim. ## 2015 - 2015-12-31 to 2016-12-31 | money | cash_and_equivalents | 147,000,000 United States dollar | superseded | [clm_431EB013A510](/claim/clm_431EB013A510.md) - 2015-12-31 to 2016-12-31 | money | total_equity | 4,793,000,000 United States dollar | superseded | [clm_24CFDAA71E08](/claim/clm_24CFDAA71E08.md) ## 2016 - 2016-12-31 to 2017-09-30 | money | cash_and_equivalents | 524,000,000 United States dollar | superseded | [clm_203D446B8327](/claim/clm_203D446B8327.md) - 2016-12-31 to 2017-12-31 | money | net_income | 1,500,000,000 United States dollar | superseded | [clm_387EDD119ED8](/claim/clm_387EDD119ED8.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 2,247,000,000 United States dollar | superseded | [clm_1A866A88BF1E](/claim/clm_1A866A88BF1E.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 92,000,000 United States dollar | superseded | [clm_48BBD46497DF](/claim/clm_48BBD46497DF.md) - 2016-12-31 to 2017-12-31 | money | revenue | 10,534,000,000 United States dollar | superseded | [clm_E760852B80BE](/claim/clm_E760852B80BE.md) - 2016-12-31 to 2017-06-30 | money | total_equity | 5,441,000,000 United States dollar | superseded | [clm_8F83824AC159](/claim/clm_8F83824AC159.md) ## 2017 - 2017-06-01 to 2017-07-12 | other | registrant_name | ZAMALIGHT PLC | superseded | [clm_0F8DD79A178E](/claim/clm_0F8DD79A178E.md) - 2017-06-30 to 2017-09-30 | money | total_equity | -462,640 United States dollar | superseded | [clm_E07176B05702](/claim/clm_E07176B05702.md) - 2017-07-12 | other | registrant_name | LINDE PLC | valid | [clm_7882406A5992](/claim/clm_7882406A5992.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 83,342 United States dollar | superseded | [clm_7882A8991E91](/claim/clm_7882A8991E91.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | -290,825 United States dollar | superseded | [clm_FA6DADFE2C21](/claim/clm_FA6DADFE2C21.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | -290,825 United States dollar | superseded | [clm_02C044E5BE43](/claim/clm_02C044E5BE43.md) - 2017-09-30 to 2018-09-30 | money | shares_outstanding | 25,000 shares | superseded | [clm_053213B1A986](/claim/clm_053213B1A986.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 9,067,652 United States dollar | superseded | [clm_0639EAB53B90](/claim/clm_0639EAB53B90.md) - 2017-09-30 to 2017-12-31 | money | total_equity | -774,997 United States dollar | superseded | [clm_B505C4EC43AB](/claim/clm_B505C4EC43AB.md) - 2017-12-31 to 2018-09-30 | money | cash_and_equivalents | 617,000,000 United States dollar | superseded | [clm_2C77A817A3E2](/claim/clm_2C77A817A3E2.md) - 2017-12-31 to 2018-12-31 | money | net_income | 1,247,000,000 United States dollar | superseded | [clm_5C3FA2BA83D5](/claim/clm_5C3FA2BA83D5.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 2,444,000,000 United States dollar | superseded | [clm_5D983CAB6114](/claim/clm_5D983CAB6114.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 93,000,000 United States dollar | superseded | [clm_AF2201E26E16](/claim/clm_AF2201E26E16.md) - 2017-12-31 to 2018-12-31 | money | revenue | 11,437,000,000 United States dollar | superseded | [clm_47E8D7B92026](/claim/clm_47E8D7B92026.md) - 2017-12-31 to 2018-09-30 | money | total_assets | 20,436,000,000 United States dollar | superseded | [clm_448B3481E6EB](/claim/clm_448B3481E6EB.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 6,018,000,000 United States dollar | superseded | [clm_FCF31F039732](/claim/clm_FCF31F039732.md) ## 2018 - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 462,000,000 United States dollar | superseded | [clm_707A4BD481D4](/claim/clm_707A4BD481D4.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 653,000,000 United States dollar | superseded | [clm_BEAF7FF80D51](/claim/clm_BEAF7FF80D51.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 24,000,000 United States dollar | superseded | [clm_9FA5FBD5F5B3](/claim/clm_9FA5FBD5F5B3.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 2,983,000,000 United States dollar | superseded | [clm_AE2B30203AAE](/claim/clm_AE2B30203AAE.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 6,884,000,000 United States dollar | superseded | [clm_22B7BC2DEF92](/claim/clm_22B7BC2DEF92.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 480,000,000 United States dollar | superseded | [clm_A6299BF725C6](/claim/clm_A6299BF725C6.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 689,000,000 United States dollar | superseded | [clm_C16F834846AB](/claim/clm_C16F834846AB.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 24,000,000 United States dollar | superseded | [clm_91BB5057A474](/claim/clm_91BB5057A474.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 3,044,000,000 United States dollar | superseded | [clm_EF8B67590D38](/claim/clm_EF8B67590D38.md) - 2018-06-30 to 2018-09-30 | money | total_equity | 6,528,000,000 United States dollar | superseded | [clm_29EB8D6DFBB2](/claim/clm_29EB8D6DFBB2.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 104,942 United States dollar | superseded | [clm_844DC12D1BCB](/claim/clm_844DC12D1BCB.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | -4,553,926 United States dollar | superseded | [clm_E777052087D9](/claim/clm_E777052087D9.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | -4,553,926 United States dollar | superseded | [clm_C3EE24AEE227](/claim/clm_C3EE24AEE227.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 23,000,000 United States dollar | superseded | [clm_EB7028C050B6](/claim/clm_EB7028C050B6.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 3,008,000,000 United States dollar | superseded | [clm_FB63CF9810F4](/claim/clm_FB63CF9810F4.md) - 2018-09-30 to 2019-02-28 | money | shares_outstanding | 551,054,569 shares | superseded | [clm_913FB5465033](/claim/clm_913FB5465033.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 8,929,551 United States dollar | superseded | [clm_22D69DFA51A9](/claim/clm_22D69DFA51A9.md) - 2018-09-30 to 2018-12-31 | money | total_equity | -11,151,516 United States dollar | superseded | [clm_D102DB6A31EF](/claim/clm_D102DB6A31EF.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 4,466,000,000 United States dollar | superseded | [clm_B2E5C53243D3](/claim/clm_B2E5C53243D3.md) - 2018-12-31 to 2019-12-31 | money | net_income | 4,381,000,000 United States dollar | superseded | [clm_95EA5FB97E69](/claim/clm_95EA5FB97E69.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 5,247,000,000 United States dollar | superseded | [clm_77BBF793191A](/claim/clm_77BBF793191A.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 113,000,000 United States dollar | superseded | [clm_F6A0634AFC11](/claim/clm_F6A0634AFC11.md) - 2018-12-31 to 2019-12-31 | money | revenue | 14,900,000,000 United States dollar | superseded | [clm_CDE8027FC1D3](/claim/clm_CDE8027FC1D3.md) - 2018-12-31 to 2019-03-31 | money | total_assets | 93,386,000,000 United States dollar | superseded | [clm_0CB4DED18333](/claim/clm_0CB4DED18333.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 51,596,000,000 United States dollar | superseded | [clm_CD5345263427](/claim/clm_CD5345263427.md) ## 2019 - 2019-02-28 to 2019-04-30 | money | shares_outstanding | 544,910,125 shares | superseded | [clm_AE1CE3A9CD69](/claim/clm_AE1CE3A9CD69.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 5,791,000,000 United States dollar | superseded | [clm_24EFC8B9909E](/claim/clm_24EFC8B9909E.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 517,000,000 United States dollar | superseded | [clm_52258BF8FD91](/claim/clm_52258BF8FD91.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 609,000,000 United States dollar | superseded | [clm_C94FA241C401](/claim/clm_C94FA241C401.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 46,000,000 United States dollar | superseded | [clm_1EF9DD1A9141](/claim/clm_1EF9DD1A9141.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 6,944,000,000 United States dollar | superseded | [clm_FBF1E903F5C5](/claim/clm_FBF1E903F5C5.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 91,641,000,000 United States dollar | superseded | [clm_33FAAE489371](/claim/clm_33FAAE489371.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 51,175,000,000 United States dollar | superseded | [clm_B01509BE1D3B](/claim/clm_B01509BE1D3B.md) - 2019-04-30 to 2019-07-31 | money | shares_outstanding | 542,766,214 shares | superseded | [clm_04DE1DF320EF](/claim/clm_04DE1DF320EF.md) - 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 2,686,000,000 United States dollar | superseded | [clm_9395624F4C95](/claim/clm_9395624F4C95.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 522,000,000 United States dollar | superseded | [clm_1150796927D0](/claim/clm_1150796927D0.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 669,000,000 United States dollar | superseded | [clm_1C77ED13F238](/claim/clm_1C77ED13F238.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 45,000,000 United States dollar | superseded | [clm_7174BCE00FAC](/claim/clm_7174BCE00FAC.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 7,204,000,000 United States dollar | superseded | [clm_AC72E240859B](/claim/clm_AC72E240859B.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 87,189,000,000 United States dollar | superseded | [clm_807F0A7EBCF8](/claim/clm_807F0A7EBCF8.md) - 2019-06-30 to 2019-09-30 | money | total_equity | 50,564,000,000 United States dollar | superseded | [clm_FD5F4E540757](/claim/clm_FD5F4E540757.md) - 2019-07-31 to 2019-10-31 | money | shares_outstanding | 540,591,490 shares | superseded | [clm_BCB1010E1639](/claim/clm_BCB1010E1639.md) - 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 2,120,000,000 United States dollar | superseded | [clm_FF86AC4C10B1](/claim/clm_FF86AC4C10B1.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 735,000,000 United States dollar | superseded | [clm_1571F8735E34](/claim/clm_1571F8735E34.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 1,000,000,000 United States dollar | superseded | [clm_44CFA32FE31F](/claim/clm_44CFA32FE31F.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_D6BE5BDA1B16](/claim/clm_D6BE5BDA1B16.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 7,000,000,000 United States dollar | superseded | [clm_1D9ADC9B2A59](/claim/clm_1D9ADC9B2A59.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 84,394,000,000 United States dollar | superseded | [clm_52359471ACD5](/claim/clm_52359471ACD5.md) - 2019-09-30 to 2019-12-31 | money | total_equity | 48,953,000,000 United States dollar | superseded | [clm_C59F6825BC0B](/claim/clm_C59F6825BC0B.md) - 2019-10-31 to 2020-01-31 | money | shares_outstanding | 537,175,977 shares | superseded | [clm_99787158CDD9](/claim/clm_99787158CDD9.md) - 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 2,700,000,000 United States dollar | superseded | [clm_F7612C76957B](/claim/clm_F7612C76957B.md) - 2019-12-31 to 2020-12-31 | money | net_income | 2,285,000,000 United States dollar | superseded | [clm_18B6E00D2FBE](/claim/clm_18B6E00D2FBE.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 2,933,000,000 United States dollar | superseded | [clm_D8195FCEBEE6](/claim/clm_D8195FCEBEE6.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 184,000,000 United States dollar | superseded | [clm_C20D3FDB5E06](/claim/clm_C20D3FDB5E06.md) - 2019-12-31 to 2020-12-31 | money | revenue | 28,228,000,000 United States dollar | superseded | [clm_71AFBFA22D8E](/claim/clm_71AFBFA22D8E.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 86,612,000,000 United States dollar | superseded | [clm_556C073FBEBF](/claim/clm_556C073FBEBF.md) - 2019-12-31 to 2020-03-31 | money | total_equity | 49,074,000,000 United States dollar | superseded | [clm_3DE2CEBD5CDB](/claim/clm_3DE2CEBD5CDB.md) ## 2020 - 2020-01-31 to 2020-04-30 | money | shares_outstanding | 532,959,736 shares | superseded | [clm_1CAF9B74A049](/claim/clm_1CAF9B74A049.md) - 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 4,014,000,000 United States dollar | superseded | [clm_2BDC37D957CA](/claim/clm_2BDC37D957CA.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 573,000,000 United States dollar | superseded | [clm_4FD87C7E7E0C](/claim/clm_4FD87C7E7E0C.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 733,000,000 United States dollar | superseded | [clm_B1CF592FE1F1](/claim/clm_B1CF592FE1F1.md) - 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 44,000,000 United States dollar | superseded | [clm_33B455C563BA](/claim/clm_33B455C563BA.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 6,739,000,000 United States dollar | superseded | [clm_470290BE8D1D](/claim/clm_470290BE8D1D.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 84,369,000,000 United States dollar | superseded | [clm_432D8815E3B6](/claim/clm_432D8815E3B6.md) - 2020-03-31 to 2020-06-30 | money | total_equity | 44,776,000,000 United States dollar | superseded | [clm_C1C1218EB423](/claim/clm_C1C1218EB423.md) - 2020-04-30 to 2020-06-30 | money | shares_outstanding | 525,185,319 shares | superseded | [clm_FCC1075EE083](/claim/clm_FCC1075EE083.md) - 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 4,941,000,000 United States dollar | superseded | [clm_BF644FFFB757](/claim/clm_BF644FFFB757.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 458,000,000 United States dollar | superseded | [clm_39782CA13262](/claim/clm_39782CA13262.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 591,000,000 United States dollar | superseded | [clm_A0A46141A8C2](/claim/clm_A0A46141A8C2.md) - 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 34,000,000 United States dollar | superseded | [clm_21E3476C413F](/claim/clm_21E3476C413F.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 6,377,000,000 United States dollar | superseded | [clm_C4DC63E2D735](/claim/clm_C4DC63E2D735.md) - 2020-06-30 to 2020-09-30 | money | shares_outstanding | 525,360,032 shares | superseded | [clm_E3832A57AF8E](/claim/clm_E3832A57AF8E.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 85,856,000,000 United States dollar | superseded | [clm_C243FC24D755](/claim/clm_C243FC24D755.md) - 2020-06-30 to 2020-09-30 | money | total_equity | 45,537,000,000 United States dollar | superseded | [clm_19B35D0034C0](/claim/clm_19B35D0034C0.md) - 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 5,199,000,000 United States dollar | superseded | [clm_CB45982A0B6F](/claim/clm_CB45982A0B6F.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 700,000,000 United States dollar | superseded | [clm_1470AA096E4C](/claim/clm_1470AA096E4C.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 969,000,000 United States dollar | superseded | [clm_7B6EE83D075C](/claim/clm_7B6EE83D075C.md) - 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_941D6CCEDA14](/claim/clm_941D6CCEDA14.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 6,855,000,000 United States dollar | superseded | [clm_E5FBEE549BAE](/claim/clm_E5FBEE549BAE.md) - 2020-09-30 to 2021-01-31 | money | shares_outstanding | 524,856,691 shares | superseded | [clm_D86C499084A1](/claim/clm_D86C499084A1.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 87,209,000,000 United States dollar | superseded | [clm_1409CB7A6EC1](/claim/clm_1409CB7A6EC1.md) - 2020-09-30 to 2020-12-31 | money | total_equity | 46,175,000,000 United States dollar | superseded | [clm_21F67DD4AF02](/claim/clm_21F67DD4AF02.md) - 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 3,754,000,000 United States dollar | superseded | [clm_3EDB3E3094D5](/claim/clm_3EDB3E3094D5.md) - 2020-12-31 to 2021-12-31 | money | net_income | 2,501,000,000 United States dollar | superseded | [clm_07587D908612](/claim/clm_07587D908612.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 3,322,000,000 United States dollar | superseded | [clm_F7F19BC90F6F](/claim/clm_F7F19BC90F6F.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 152,000,000 United States dollar | superseded | [clm_1FAC6408DFD9](/claim/clm_1FAC6408DFD9.md) - 2020-12-31 to 2021-12-31 | money | revenue | 27,243,000,000 United States dollar | superseded | [clm_9C76DAF18D3C](/claim/clm_9C76DAF18D3C.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 88,229,000,000 United States dollar | superseded | [clm_3F6F72751B1A](/claim/clm_3F6F72751B1A.md) - 2020-12-31 to 2021-03-31 | money | total_equity | 47,317,000,000 United States dollar | superseded | [clm_EAE0023129E7](/claim/clm_EAE0023129E7.md) ## 2021 - 2021-01-31 to 2021-03-31 | money | shares_outstanding | 522,836,425 shares | superseded | [clm_AC296693646F](/claim/clm_AC296693646F.md) - 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 4,096,000,000 United States dollar | superseded | [clm_7547CB1865D3](/claim/clm_7547CB1865D3.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 980,000,000 United States dollar | superseded | [clm_A99DB74A63C9](/claim/clm_A99DB74A63C9.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 1,213,000,000 United States dollar | superseded | [clm_555A7AB864E0](/claim/clm_555A7AB864E0.md) - 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 35,000,000 United States dollar | superseded | [clm_58B8B4F6B139](/claim/clm_58B8B4F6B139.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 7,243,000,000 United States dollar | superseded | [clm_4B455648B303](/claim/clm_4B455648B303.md) - 2021-03-31 to 2021-06-30 | money | shares_outstanding | 520,208,493 shares | superseded | [clm_A70DCBEBA973](/claim/clm_A70DCBEBA973.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 84,993,000,000 United States dollar | superseded | [clm_80A86B510964](/claim/clm_80A86B510964.md) - 2021-03-31 to 2021-06-30 | money | total_equity | 46,210,000,000 United States dollar | superseded | [clm_067D958D1465](/claim/clm_067D958D1465.md) - 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 3,137,000,000 United States dollar | superseded | [clm_30A9D6113D7A](/claim/clm_30A9D6113D7A.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 841,000,000 United States dollar | superseded | [clm_34684DD36A70](/claim/clm_34684DD36A70.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | 1,142,000,000 United States dollar | superseded | [clm_F614CD6589BA](/claim/clm_F614CD6589BA.md) - 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 34,000,000 United States dollar | superseded | [clm_931E996EE555](/claim/clm_931E996EE555.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 7,584,000,000 United States dollar | superseded | [clm_D936A2B009B4](/claim/clm_D936A2B009B4.md) - 2021-06-30 to 2021-09-30 | money | shares_outstanding | 516,411,320 shares | superseded | [clm_EB9347AB63A2](/claim/clm_EB9347AB63A2.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 84,345,000,000 United States dollar | superseded | [clm_432AC3B009C3](/claim/clm_432AC3B009C3.md) - 2021-06-30 to 2021-09-30 | money | total_equity | 45,777,000,000 United States dollar | superseded | [clm_115A709D1FCB](/claim/clm_115A709D1FCB.md) - 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 4,700,000,000 United States dollar | superseded | [clm_B871540F6FF1](/claim/clm_B871540F6FF1.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 979,000,000 United States dollar | superseded | [clm_8617ABB0D8BD](/claim/clm_8617ABB0D8BD.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 1,292,000,000 United States dollar | superseded | [clm_8A67D12A6723](/claim/clm_8A67D12A6723.md) - 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_42F5B71FDC8A](/claim/clm_42F5B71FDC8A.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 7,668,000,000 United States dollar | superseded | [clm_ADF326C21363](/claim/clm_ADF326C21363.md) - 2021-09-30 to 2022-01-31 | money | shares_outstanding | 512,554,731 shares | superseded | [clm_10D7792856EE](/claim/clm_10D7792856EE.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 84,191,000,000 United States dollar | superseded | [clm_719CE74C0715](/claim/clm_719CE74C0715.md) - 2021-09-30 to 2021-12-31 | money | total_equity | 44,323,000,000 United States dollar | superseded | [clm_AF45D3E2C629](/claim/clm_AF45D3E2C629.md) - 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 2,823,000,000 United States dollar | superseded | [clm_010F450C4D3D](/claim/clm_010F450C4D3D.md) - 2021-12-31 to 2022-12-31 | money | net_income | 3,826,000,000 United States dollar | superseded | [clm_CC800C0B4FA3](/claim/clm_CC800C0B4FA3.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 4,984,000,000 United States dollar | superseded | [clm_FC495A496E33](/claim/clm_FC495A496E33.md) - 2021-12-31 to 2022-12-31 | money | research_and_development | 143,000,000 United States dollar | superseded | [clm_DAF70C67C567](/claim/clm_DAF70C67C567.md) - 2021-12-31 to 2022-12-31 | money | revenue | 30,793,000,000 United States dollar | superseded | [clm_C4E9F10FCE4B](/claim/clm_C4E9F10FCE4B.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 81,605,000,000 United States dollar | superseded | [clm_D0B29B0EF685](/claim/clm_D0B29B0EF685.md) - 2021-12-31 to 2022-03-31 | money | total_equity | 44,035,000,000 United States dollar | superseded | [clm_00B57882350E](/claim/clm_00B57882350E.md) ## 2022 - 2022-01-31 to 2022-03-31 | money | shares_outstanding | 507,744,577 shares | superseded | [clm_99E6644238C0](/claim/clm_99E6644238C0.md) - 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 4,464,000,000 United States dollar | superseded | [clm_E01735A64E5B](/claim/clm_E01735A64E5B.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 1,174,000,000 United States dollar | superseded | [clm_F15F578C40B3](/claim/clm_F15F578C40B3.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 1,480,000,000 United States dollar | superseded | [clm_4542D5DF2785](/claim/clm_4542D5DF2785.md) - 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 35,000,000 United States dollar | superseded | [clm_F75A98597C42](/claim/clm_F75A98597C42.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 8,211,000,000 United States dollar | superseded | [clm_A551A00F9F4D](/claim/clm_A551A00F9F4D.md) - 2022-03-31 to 2022-06-30 | money | shares_outstanding | 503,281,693 shares | superseded | [clm_A33C4A2107E6](/claim/clm_A33C4A2107E6.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 82,767,000,000 United States dollar | superseded | [clm_AC51BA684D84](/claim/clm_AC51BA684D84.md) - 2022-03-31 to 2022-06-30 | money | total_equity | 42,963,000,000 United States dollar | superseded | [clm_766A07489E7C](/claim/clm_766A07489E7C.md) - 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 3,655,000,000 United States dollar | superseded | [clm_4B879B229D69](/claim/clm_4B879B229D69.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 372,000,000 United States dollar | superseded | [clm_EEBBEB84A1AF](/claim/clm_EEBBEB84A1AF.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 589,000,000 United States dollar | superseded | [clm_359F224CAD23](/claim/clm_359F224CAD23.md) - 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 37,000,000 United States dollar | superseded | [clm_4EC8266DCEA1](/claim/clm_4EC8266DCEA1.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 8,457,000,000 United States dollar | superseded | [clm_CD376022B96E](/claim/clm_CD376022B96E.md) - 2022-06-30 to 2022-09-30 | money | shares_outstanding | 498,365,588 shares | superseded | [clm_A1F24D59E7D5](/claim/clm_A1F24D59E7D5.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 77,885,000,000 United States dollar | superseded | [clm_2C12C8AB0D56](/claim/clm_2C12C8AB0D56.md) - 2022-06-30 to 2022-09-30 | money | total_equity | 39,674,000,000 United States dollar | superseded | [clm_6CC505C06065](/claim/clm_6CC505C06065.md) - 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 3,756,000,000 United States dollar | superseded | [clm_252505ECA1EC](/claim/clm_252505ECA1EC.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 1,273,000,000 United States dollar | superseded | [clm_F4816EA59271](/claim/clm_F4816EA59271.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 1,613,000,000 United States dollar | superseded | [clm_B3D472A7A7C2](/claim/clm_B3D472A7A7C2.md) - 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 35,000,000 United States dollar | superseded | [clm_8F0E8DB8FF5C](/claim/clm_8F0E8DB8FF5C.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 8,797,000,000 United States dollar | superseded | [clm_357FEAC6B10B](/claim/clm_357FEAC6B10B.md) - 2022-09-30 to 2023-01-31 | money | shares_outstanding | 494,379,532 shares | superseded | [clm_A2141C5A6A0C](/claim/clm_A2141C5A6A0C.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 74,323,000,000 United States dollar | superseded | [clm_AC68A1511E96](/claim/clm_AC68A1511E96.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 37,628,000,000 United States dollar | superseded | [clm_49FCFFF848E3](/claim/clm_49FCFFF848E3.md) - 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 5,436,000,000 United States dollar | superseded | [clm_2DA57F435A14](/claim/clm_2DA57F435A14.md) - 2022-12-31 to 2023-12-31 | money | net_income | 4,147,000,000 United States dollar | superseded | [clm_5529DC955F2D](/claim/clm_5529DC955F2D.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 5,369,000,000 United States dollar | superseded | [clm_B7A383D5F582](/claim/clm_B7A383D5F582.md) - 2022-12-31 to 2023-12-31 | money | research_and_development | 143,000,000 United States dollar | superseded | [clm_6FF8D22F385D](/claim/clm_6FF8D22F385D.md) - 2022-12-31 to 2023-12-31 | money | revenue | 33,364,000,000 United States dollar | superseded | [clm_E7BD3603DE4F](/claim/clm_E7BD3603DE4F.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 79,658,000,000 United States dollar | superseded | [clm_9D63EDCDF82E](/claim/clm_9D63EDCDF82E.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 40,028,000,000 United States dollar | superseded | [clm_D16C83EA4CD2](/claim/clm_D16C83EA4CD2.md) ## 2023 - 2023-01-31 to 2023-03-31 | money | shares_outstanding | 492,160,806 shares | superseded | [clm_1DC91D88F070](/claim/clm_1DC91D88F070.md) - 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 4,962,000,000 United States dollar | superseded | [clm_B50D4BB35A3E](/claim/clm_B50D4BB35A3E.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 1,516,000,000 United States dollar | superseded | [clm_4282906D2F25](/claim/clm_4282906D2F25.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 1,933,000,000 United States dollar | superseded | [clm_C7E05847B88D](/claim/clm_C7E05847B88D.md) - 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_F70715A95984](/claim/clm_F70715A95984.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 8,193,000,000 United States dollar | superseded | [clm_9D28EE64FB96](/claim/clm_9D28EE64FB96.md) - 2023-03-31 to 2023-06-30 | money | shares_outstanding | 490,251,988 shares | superseded | [clm_F16289CEE8A8](/claim/clm_F16289CEE8A8.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 80,308,000,000 United States dollar | superseded | [clm_A14A1F0D611B](/claim/clm_A14A1F0D611B.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 39,970,000,000 United States dollar | superseded | [clm_A677CDE74788](/claim/clm_A677CDE74788.md) - 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 3,357,000,000 United States dollar | superseded | [clm_9DD0F3578304](/claim/clm_9DD0F3578304.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 1,575,000,000 United States dollar | superseded | [clm_B3258E4CECDF](/claim/clm_B3258E4CECDF.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 2,011,000,000 United States dollar | superseded | [clm_A574176C2592](/claim/clm_A574176C2592.md) - 2023-06-30 to 2023-09-30 | money | quarterly_research_and_development | 35,000,000 United States dollar | superseded | [clm_6EB8D4338737](/claim/clm_6EB8D4338737.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 8,204,000,000 United States dollar | superseded | [clm_06B46A126BFF](/claim/clm_06B46A126BFF.md) - 2023-06-30 to 2023-09-30 | money | shares_outstanding | 487,945,864 shares | superseded | [clm_C633EFA01EC2](/claim/clm_C633EFA01EC2.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 78,718,000,000 United States dollar | superseded | [clm_19390EF5B4C9](/claim/clm_19390EF5B4C9.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 39,911,000,000 United States dollar | superseded | [clm_65F48081EAE0](/claim/clm_65F48081EAE0.md) - 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 3,894,000,000 United States dollar | superseded | [clm_8BA05AC1A020](/claim/clm_8BA05AC1A020.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 1,565,000,000 United States dollar | superseded | [clm_08CD45A7AAF9](/claim/clm_08CD45A7AAF9.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 2,052,000,000 United States dollar | superseded | [clm_BA169E60E85F](/claim/clm_BA169E60E85F.md) - 2023-09-30 to 2024-03-31 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_E5D819909504](/claim/clm_E5D819909504.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 8,155,000,000 United States dollar | superseded | [clm_15C410561540](/claim/clm_15C410561540.md) - 2023-09-30 to 2024-01-31 | money | shares_outstanding | 484,890,486 shares | superseded | [clm_97565295604C](/claim/clm_97565295604C.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 77,827,000,000 United States dollar | superseded | [clm_AAEF3D3E4CAA](/claim/clm_AAEF3D3E4CAA.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 38,898,000,000 United States dollar | superseded | [clm_566702137CA6](/claim/clm_566702137CA6.md) - 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 4,664,000,000 United States dollar | superseded | [clm_3E390E82A4C8](/claim/clm_3E390E82A4C8.md) - 2023-12-31 to 2024-12-31 | money | net_income | 6,199,000,000 United States dollar | superseded | [clm_4FA1DF9DF0EC](/claim/clm_4FA1DF9DF0EC.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 8,024,000,000 United States dollar | superseded | [clm_9E6F7D6AEE27](/claim/clm_9E6F7D6AEE27.md) - 2023-12-31 to 2024-12-31 | money | research_and_development | 146,000,000 United States dollar | superseded | [clm_FC2BF592AE13](/claim/clm_FC2BF592AE13.md) - 2023-12-31 to 2024-12-31 | money | revenue | 32,854,000,000 United States dollar | superseded | [clm_48F2CF0E559B](/claim/clm_48F2CF0E559B.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 80,811,000,000 United States dollar | superseded | [clm_D3E58479CBF7](/claim/clm_D3E58479CBF7.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 39,720,000,000 United States dollar | superseded | [clm_A3C539DA5D57](/claim/clm_A3C539DA5D57.md) ## 2024 - 2024-01-31 to 2024-03-31 | money | shares_outstanding | 481,576,472 shares | superseded | [clm_8AFA96519051](/claim/clm_8AFA96519051.md) - 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 4,848,000,000 United States dollar | superseded | [clm_CFAAC06CDFED](/claim/clm_CFAAC06CDFED.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 1,627,000,000 United States dollar | superseded | [clm_BA7450CF2B4F](/claim/clm_BA7450CF2B4F.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 2,095,000,000 United States dollar | superseded | [clm_256039FE6322](/claim/clm_256039FE6322.md) - 2024-03-31 to 2024-06-30 | money | quarterly_research_and_development | 38,000,000 United States dollar | superseded | [clm_02E1239D3E0D](/claim/clm_02E1239D3E0D.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 8,100,000,000 United States dollar | superseded | [clm_F53DED09298D](/claim/clm_F53DED09298D.md) - 2024-03-31 to 2024-06-30 | money | shares_outstanding | 480,676,281 shares | superseded | [clm_EFEF92F41784](/claim/clm_EFEF92F41784.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 80,347,000,000 United States dollar | superseded | [clm_5DBF6F3DDC21](/claim/clm_5DBF6F3DDC21.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 38,829,000,000 United States dollar | superseded | [clm_734131A82E26](/claim/clm_734131A82E26.md) - 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 4,626,000,000 United States dollar | superseded | [clm_F7769A8E1F0F](/claim/clm_F7769A8E1F0F.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 1,663,000,000 United States dollar | superseded | [clm_DB7C4EB5E11D](/claim/clm_DB7C4EB5E11D.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | 2,184,000,000 United States dollar | superseded | [clm_748F2EDD99FB](/claim/clm_748F2EDD99FB.md) - 2024-06-30 to 2024-09-30 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_C47FC08173EB](/claim/clm_C47FC08173EB.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 8,267,000,000 United States dollar | superseded | [clm_76248C0A7F1A](/claim/clm_76248C0A7F1A.md) - 2024-06-30 to 2024-09-30 | money | shares_outstanding | 477,502,737 shares | superseded | [clm_9494876FF515](/claim/clm_9494876FF515.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 80,215,000,000 United States dollar | superseded | [clm_626144786974](/claim/clm_626144786974.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 38,179,000,000 United States dollar | superseded | [clm_F5E6A9BC2197](/claim/clm_F5E6A9BC2197.md) - 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 5,187,000,000 United States dollar | superseded | [clm_CA9ACCD3CFF2](/claim/clm_CA9ACCD3CFF2.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 1,550,000,000 United States dollar | superseded | [clm_50C27E359657](/claim/clm_50C27E359657.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 2,086,000,000 United States dollar | superseded | [clm_A562A6F86A53](/claim/clm_A562A6F86A53.md) - 2024-09-30 to 2025-03-31 | money | quarterly_research_and_development | 37,000,000 United States dollar | superseded | [clm_9DB58C162683](/claim/clm_9DB58C162683.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 8,356,000,000 United States dollar | superseded | [clm_6896932C1E18](/claim/clm_6896932C1E18.md) - 2024-09-30 to 2025-01-31 | money | shares_outstanding | 476,157,903 shares | superseded | [clm_8F74D0A38F3F](/claim/clm_8F74D0A38F3F.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 82,546,000,000 United States dollar | superseded | [clm_02314F944135](/claim/clm_02314F944135.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 39,173,000,000 United States dollar | superseded | [clm_DB388E6908A5](/claim/clm_DB388E6908A5.md) - 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 4,850,000,000 United States dollar | superseded | [clm_D82841499F43](/claim/clm_D82841499F43.md) - 2024-12-31 to 2025-12-31 | money | net_income | 6,565,000,000 United States dollar | superseded | [clm_3CE9B1AD8033](/claim/clm_3CE9B1AD8033.md) - 2024-12-31 to 2025-12-31 | money | operating_income | 8,635,000,000 United States dollar | superseded | [clm_37079A92663C](/claim/clm_37079A92663C.md) - 2024-12-31 to 2025-12-31 | money | research_and_development | 150,000,000 United States dollar | superseded | [clm_FB49D4172B39](/claim/clm_FB49D4172B39.md) - 2024-12-31 to 2025-12-31 | money | revenue | 33,005,000,000 United States dollar | superseded | [clm_758B08B41396](/claim/clm_758B08B41396.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 80,147,000,000 United States dollar | superseded | [clm_06255718F408](/claim/clm_06255718F408.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 38,092,000,000 United States dollar | superseded | [clm_06A2B24AB519](/claim/clm_06A2B24AB519.md) ## 2025 - 2025-01-31 to 2025-03-31 | money | shares_outstanding | 472,911,618 shares | superseded | [clm_B90C87567774](/claim/clm_B90C87567774.md) - 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 5,294,000,000 United States dollar | superseded | [clm_52FFA4F96692](/claim/clm_52FFA4F96692.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 1,673,000,000 United States dollar | superseded | [clm_63731376306A](/claim/clm_63731376306A.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 2,184,000,000 United States dollar | superseded | [clm_5F1FC0C7B7CE](/claim/clm_5F1FC0C7B7CE.md) - 2025-03-31 to 2025-06-30 | money | quarterly_research_and_development | 38,000,000 United States dollar | superseded | [clm_CA1C8041672C](/claim/clm_CA1C8041672C.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 8,112,000,000 United States dollar | superseded | [clm_95EA4DA581D5](/claim/clm_95EA4DA581D5.md) - 2025-03-31 to 2025-06-30 | money | shares_outstanding | 471,294,205 shares | superseded | [clm_039C74673A34](/claim/clm_039C74673A34.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 82,704,000,000 United States dollar | superseded | [clm_E1ED0B0A274B](/claim/clm_E1ED0B0A274B.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 38,032,000,000 United States dollar | superseded | [clm_DAB7BE4289AD](/claim/clm_DAB7BE4289AD.md) - 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 4,786,000,000 United States dollar | superseded | [clm_3D438DF1A74E](/claim/clm_3D438DF1A74E.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 1,766,000,000 United States dollar | superseded | [clm_8D9B16FE2456](/claim/clm_8D9B16FE2456.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 2,354,000,000 United States dollar | superseded | [clm_20BA88AB45E5](/claim/clm_20BA88AB45E5.md) - 2025-06-30 to 2025-09-30 | money | quarterly_research_and_development | 38,000,000 United States dollar | superseded | [clm_85067CE39001](/claim/clm_85067CE39001.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 8,495,000,000 United States dollar | superseded | [clm_4F4D09D78788](/claim/clm_4F4D09D78788.md) - 2025-06-30 to 2025-09-30 | money | shares_outstanding | 468,909,532 shares | superseded | [clm_C595C52DE21A](/claim/clm_C595C52DE21A.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 86,078,000,000 United States dollar | superseded | [clm_6A7FF1292B13](/claim/clm_6A7FF1292B13.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 38,515,000,000 United States dollar | superseded | [clm_340056160D3B](/claim/clm_340056160D3B.md) - 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 4,509,000,000 United States dollar | superseded | [clm_49A486EFC1F8](/claim/clm_49A486EFC1F8.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 1,929,000,000 United States dollar | superseded | [clm_63E6044201B6](/claim/clm_63E6044201B6.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 2,367,000,000 United States dollar | superseded | [clm_977A3936528B](/claim/clm_977A3936528B.md) - 2025-09-30 to 2026-03-31 | money | quarterly_research_and_development | 36,000,000 United States dollar | superseded | [clm_118847322268](/claim/clm_118847322268.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 8,615,000,000 United States dollar | superseded | [clm_5D9EB0E8A3AA](/claim/clm_5D9EB0E8A3AA.md) - 2025-09-30 to 2026-01-31 | money | shares_outstanding | 466,948,930 shares | superseded | [clm_984EB4297FAD](/claim/clm_984EB4297FAD.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 85,993,000,000 United States dollar | superseded | [clm_F50337315639](/claim/clm_F50337315639.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 38,616,000,000 United States dollar | superseded | [clm_9F05464AE058](/claim/clm_9F05464AE058.md) - 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 5,056,000,000 United States dollar | superseded | [clm_A57E679DD40D](/claim/clm_A57E679DD40D.md) - 2025-12-31 | money | net_income | 6,898,000,000 United States dollar | valid | [clm_55C4A1E1DE56](/claim/clm_55C4A1E1DE56.md) - 2025-12-31 | money | operating_income | 8,923,000,000 United States dollar | valid | [clm_7687AFC7647C](/claim/clm_7687AFC7647C.md) - 2025-12-31 | money | research_and_development | 147,000,000 United States dollar | valid | [clm_4B81140CF5C9](/claim/clm_4B81140CF5C9.md) - 2025-12-31 | money | revenue | 33,986,000,000 United States dollar | valid | [clm_25E7A103B51B](/claim/clm_25E7A103B51B.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 86,817,000,000 United States dollar | superseded | [clm_4A18B0C4523D](/claim/clm_4A18B0C4523D.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 38,245,000,000 United States dollar | superseded | [clm_B82A2436D87D](/claim/clm_B82A2436D87D.md) ## 2026 - 2026-01-31 to 2026-03-31 | money | shares_outstanding | 463,394,156 shares | superseded | [clm_4ED975197B5F](/claim/clm_4ED975197B5F.md) - 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 3,959,000,000 United States dollar | superseded | [clm_62F647A9648C](/claim/clm_62F647A9648C.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 1,857,000,000 United States dollar | superseded | [clm_D3D0EE077C27](/claim/clm_D3D0EE077C27.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 2,439,000,000 United States dollar | superseded | [clm_A3BBDC3DF1BD](/claim/clm_A3BBDC3DF1BD.md) - 2026-03-31 to 2026-06-30 | money | quarterly_research_and_development | 38,000,000 United States dollar | superseded | [clm_3C45701872B2](/claim/clm_3C45701872B2.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 8,781,000,000 United States dollar | superseded | [clm_8D5704B996AC](/claim/clm_8D5704B996AC.md) - 2026-03-31 to 2026-06-30 | money | shares_outstanding | 462,599,539 shares | superseded | [clm_95B6B3B724A3](/claim/clm_95B6B3B724A3.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 86,315,000,000 United States dollar | superseded | [clm_125AA38C6A7D](/claim/clm_125AA38C6A7D.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 38,566,000,000 United States dollar | superseded | [clm_AC6D066FDFA9](/claim/clm_AC6D066FDFA9.md) - 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 4,898,000,000 United States dollar | superseded | [clm_7DD1EBB7B19F](/claim/clm_7DD1EBB7B19F.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 1,928,000,000 United States dollar | superseded | [clm_FFF387063BE7](/claim/clm_FFF387063BE7.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 2,554,000,000 United States dollar | superseded | [clm_03560FF3FF6D](/claim/clm_03560FF3FF6D.md) - 2026-06-30 to 2026-09-30 | money | quarterly_research_and_development | 37,000,000 United States dollar | superseded | [clm_B4544B527C2F](/claim/clm_B4544B527C2F.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 9,289,000,000 United States dollar | superseded | [clm_3BCC513C972F](/claim/clm_3BCC513C972F.md) - 2026-06-30 to 2026-09-30 | money | shares_outstanding | 460,980,163 shares | superseded | [clm_E861D8938169](/claim/clm_E861D8938169.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 88,349,000,000 United States dollar | superseded | [clm_7C59E7E40A40](/claim/clm_7C59E7E40A40.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 39,081,000,000 United States dollar | superseded | [clm_518EB50E4BB4](/claim/clm_518EB50E4BB4.md) - 2026-09-30 | money | cash_and_equivalents | 3,947,000,000 United States dollar | valid | [clm_007E3F63504C](/claim/clm_007E3F63504C.md) - 2026-09-30 | money | quarterly_net_income | 1,692,000,000 United States dollar | valid | [clm_E8812069AB91](/claim/clm_E8812069AB91.md) - 2026-09-30 | money | quarterly_operating_income | 2,150,000,000 United States dollar | valid | [clm_0EBB7887DD16](/claim/clm_0EBB7887DD16.md) - 2026-09-30 | money | quarterly_research_and_development | 37,000,000 United States dollar | valid | [clm_4D8C62B1648B](/claim/clm_4D8C62B1648B.md) - 2026-09-30 | money | quarterly_revenue | 9,404,000,000 United States dollar | valid | [clm_A786E2701D52](/claim/clm_A786E2701D52.md) - 2026-09-30 | money | shares_outstanding | 459,083,779 shares | valid | [clm_DC68350517E7](/claim/clm_DC68350517E7.md) - 2026-09-30 | money | total_assets | 88,075,000,000 United States dollar | valid | [clm_7AFFCFCC514C](/claim/clm_7AFFCFCC514C.md) - 2026-09-30 | money | total_equity | 39,422,000,000 United States dollar | valid | [clm_CC553131AA28](/claim/clm_CC553131AA28.md) ## undated - undated | other | cik | 0001707925 | valid | [clm_399902528169](/claim/clm_399902528169.md) - undated | other | fiscal_year_end | 12-31 | valid | [clm_150948BF9261](/claim/clm_150948BF9261.md) - undated to 2023-01-01 | other | headquarters | Woking Surrey | superseded | [clm_1E1E1E5E92ED](/claim/clm_1E1E1E5E92ED.md) - undated | other | listed_on | Nasdaq | valid | [clm_78AB371C638A](/claim/clm_78AB371C638A.md) - undated | other | sic_industry | Industrial Inorganic Chemicals (2810) | valid | [clm_9F5F92D5CB14](/claim/clm_9F5F92D5CB14.md) - undated | other | state_of_incorporation | L2 | valid | [clm_F881BA53A611](/claim/clm_F881BA53A611.md) - undated | other | ticker | LIN | valid | [clm_EDBE7336B8B6](/claim/clm_EDBE7336B8B6.md) - undated | other | website | https://www.linde.mx/ | unverified | [clm_4BF6FC755E60](/claim/clm_4BF6FC755E60.md) - undated | other | website | https://utsalgssted.linde.no/ | unverified | [clm_915007C483E7](/claim/clm_915007C483E7.md) - undated | other | website | https://forsaljningsstallen.linde.se/ | unverified | [clm_A0C4B56C105E](/claim/clm_A0C4B56C105E.md) - undated | other | website | http://www.linde.com/ | unverified | [clm_B2517EE3B7FF](/claim/clm_B2517EE3B7FF.md) - undated | other | website | https://www.linde-gas.se/ | unverified | [clm_DCC34E68FF54](/claim/clm_DCC34E68FF54.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.